Operating Cash Flow (Statement)

$574.50M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$574.50Mperiod endingJun 30, 2026

REGN Quarterly Cash from Operations (-$2.70M → $574.50M)

Quarterly operating cash flow (statement)

High-resolution chart · PNG

REGN operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Operating Cash Flow (Statement) — Quarterly (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	-9,378,000
Mar 31, 2001	-8,397,000
Dec 31, 2000	-3,770,000
Sep 30, 2000	-4,204,000
Jun 30, 2000	-3,349,000
Mar 31, 2000	-16,587,000
Dec 31, 1999	7,000,000
Sep 30, 1999	-7,700,000
Jun 30, 1999	-4,700,000
Mar 31, 1999	-8,400,000
Dec 31, 1998	-5,700,000
Sep 30, 1998	4,200,000
Jun 30, 1998	-4,500,000
Mar 31, 1998	-4,200,000
Dec 31, 1997	3,100,000
Sep 30, 1997	-1,700,000
Jun 30, 1997	-4,100,000
Mar 31, 1997	-3,400,000
Dec 31, 1996	-100,000
Sep 30, 1996	-7,000,000
Jun 30, 1996	-5,900,000
Mar 31, 1996	-7,300,000
Dec 31, 1995	2,100,000
Sep 30, 1995	-11,300,000
Jun 30, 1995	-2,400,000
Mar 31, 1995	-6,600,000
Dec 31, 1994	-11,400,000
Sep 30, 1994	-5,900,000
Jun 30, 1994	5,800,000
Mar 31, 1994	-9,000,000
Dec 31, 1993	-9,000,000
Sep 30, 1993	-6,000,000
Jun 30, 1993	-7,800,000
Mar 31, 1993	-7,300,000
Dec 31, 1992	-6,000,000
Sep 30, 1992	-3,800,000
Jun 30, 1992	-4,200,000
Mar 31, 1992	-3,200,000
Dec 31, 1991	-1,400,000
Sep 30, 1991	-2,700,000